Tumor immune evasion is one of the hallmarks of malignancy, and expression of the B7 family of ICPs Immune checkpoint molecules (PD-L1, PD-L2, B7-H3, B7x and HHLA2) is one mechanism of immune evasion by tumors. Here, HHLA2 is linked to neoplasm.